Table 5
Past year prevalence of cigarette smoking, heavy drinking, other illicit drugs, and use of three classes of psychoactive pharmaceuticals , by cannabis-user type, household population aged 15 or older, Canada excluding territories, 2015

Table 5
Past year prevalence of daily cigarette smoking, heavy drinking, other illicit drugs, and use of three classes of psychoactive pharmaceuticals , by cannabis-user type, household population aged 15 or older, Canada excluding territories, 2015
Table summary
This table displays the results of Past year prevalence of daily cigarette smoking Non-user, Non-medical only (NMO), Self-defined medical / non-medical (SDMNM), % and 95% confidence interval, calculated using from and to units of measure (appearing as column headers).
	%	95% confidence interval		%	95% confidence interval		%	95% confidence interval
	Non-user			Non-medical only (NMO)^{Table 5 Note ‡}			Self-defined medical / non-medical (SDMNM)
	%	from	to	%	from	to	%	from	to
Daily cigarette smoking	7.4	6.5	8.3	20.7^Note *	16.6	25.4	33.0^Note *^{Table 5 Note †}	25.1	41.9
Heavy drinking	18.1	16.9	19.5	57.1^Note *	51.6	62.4	45.4^Note *^{Table 5 Note †}	36.0	55.2
Other illicit drugs	0.3^{Note E: Use with caution}	0.2	0.5	17.4^Note *	13.7	21.7	18.1^{Note E: Use with caution}^Note *	12.1	26.1
Cocaine or heroin	0.2^{Note E: Use with caution}	0.1	0.3	8.7^Note *	6.5	11.6	9.2^{Note E: Use with caution}^Note *	5.2	15.7
Speed or methamphetamine	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable	1.5^{Note E: Use with caution}	0.8	2.9	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable
Ecstacy	0.1^{Note E: Use with caution}	0.0	0.2	6.5^Note *	4.7	8.9	2.4^{Note E: Use with caution}^Note *^{Table 5 Note †}	1.3	4.3
Hallucinogens (including salvia)	0.1^{Note E: Use with caution}	0.0	0.2	8.9^{Note E: Use with caution}^Note *	5.9	13.2	10.8^{Note E: Use with caution}^Note *	6.4	17.9
Inhalants or solvents	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable	0.0	0.0	0.0	0.0	0.0	0.0
Psychoactive pharmaceuticals
Used at least one type	20.4	19.0	21.8	24.1	20.2	28.5	47.4^Note *^{Table 5 Note †}	38.5	56.5
Used at least one type for non-therapeutic purposes	1.0^{Note E: Use with caution}	0.7	1.4	4.8^{Note E: Use with caution}^Note *	3.2	7.4	7.0^{Note E: Use with caution}^Note *	3.7	13.0
Sedatives or tranquillizers
Any use	10.0	9.0	11.0	11.6	9.0	14.7	22.0^{Note E: Use with caution}^Note *^{Table 5 Note †}	15.3	30.5
Non-therapeutic use	0.4^{Note E: Use with caution}	0.3	0.7	1.5^{Note E: Use with caution}^Note *	0.8	2.8	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable
Stimulants
Any use	0.7	0.5	0.9	4.1^{Note E: Use with caution}^Note *	2.9	5.9	6.0^{Note E: Use with caution}^Note *	3.2	11.2
Non-therapeutic use	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable	1.2^{Note E: Use with caution}	0.7	2.0	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable
Opioid pain relievers^{Table 5 Note §}
Any use	12.4	11.2	13.7	12.4	9.6	16.0	32.6^Note *^{Table 5 Note †}	24.9	41.3
Non-therapeutic use	0.6^{Note E: Use with caution}	0.3	1.0	3.3^{Note E: Use with caution}^Note *	1.8	5.8	Note F: too unreliable to be published	Note ...: not applicable	Note ...: not applicable
... not applicable ^E use with caution F too unreliable to be published Note * significantly different from the non-user category (p<0.05) Return to note * Note † significantly different from the Non-Medical Only (NMO) users category (p<0.05) Return to note † Note ‡ one-time users excluded Return to note ‡ Note § Composite combining information from four questions about products containing codeine, oxycodone, fentanyl and other opioids Return to note § Source: 2015 Canadian Tobacco Alcohol and Drugs Survey.

Date modified:: 2018-07-18

Language selection

Search and menus

Search

Table 5
Past year prevalence of cigarette smoking, heavy drinking, other illicit drugs, and use of three classes of psychoactive pharmaceuticals , by cannabis-user type, household population aged 15 or older, Canada excluding territories, 2015

Table 5 Past year prevalence of cigarette smoking, heavy drinking, other illicit drugs, and use of three classes of psychoactive pharmaceuticals , by cannabis-user type, household population aged 15 or older, Canada excluding territories, 2015

Note of appreciation

Standards of service to the public

Copyright

Table 5
Past year prevalence of cigarette smoking, heavy drinking, other illicit drugs, and use of three classes of psychoactive pharmaceuticals , by cannabis-user type, household population aged 15 or older, Canada excluding territories, 2015